• Return to Headlines

Shares of NKTR Down 22.3% Since Downtrend Call on Shares

By Nick Russo

SmarTrend identified a Downtrend for Nektar Therapeut (NASDAQ:NKTR) on September 13th, 2018 at $62.24. In approximately 4 weeks, Nektar Therapeut has returned 22.29% as of today's recent price of $48.36.

In the past 52 weeks, Nektar Therapeut share prices have been bracketed by a low of $22.72 and a high of $111.36 and are now at $48.36, 113% above that low price. Over the past week, the 200-day moving average (MA) has remained constant while the 50-day MA has remained constant.

Nektar Therapeutics is a clinical-stage biopharmaceutical company which develops a pipeline of drug candidates that utilize company platforms. The Company's product pipeline is comprised of early to late stage drug candidates across a number of therapeutic areas including oncology, pain, anti-infectives, anti-viral, and immunology.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any changes in momentum for shares of Nektar Therapeut.

Log in and add Nektar Therapeut (NKTR) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights nektar therapeut

Ticker(s): NKTR